U.S. Makes Forced Labor a “Top-Tier” Compliance Issue as Chinese Government Continues to Commit Human Rights Violations

China has long persecuted individuals in their Xinjiang region, mostly Uyghurs and Turkic Muslims. Specifically, the Chinese government has a long history of forcing Uyghurs and Turkic Muslims to do manual labor. These human rights violations prompted President Biden to sign the Uyghur Forced Labor Prevention Act (UFLPA) into law late last year. On June 21, 2022, the UFLPA went into effect, blocking the importation of goods made from forced labor in the Xinjiang region of China. The law has four main functions. It employs both an enforcement strategy and a diplomatic strategy, it applies a presumption that all goods from the Xinjiang region are barred, and it has required sanctions. Although the United States had previously restricted imports from the Xinjiang region under the Trump administration, this is the furthest step forward the US government has taken to eliminate imports from the region all together.

OSHA’s New Directive: An Incentive or a Drawback?

In September 2022, the Occupational Safety and Health Administration (OSHA) issued a new instruction which broadens the scope of the agency’s inspection program, the Severe Violator Enforcement Program (SVEP). The previous directive, which went into effect in 2010, allowed OSHA to place employers in the program if its employees committed certain serious violations, especially if they had already been cited for the violation once or received a failure-to-abate notice. The new instruction allows OSHA to place employers in the program that probably would not have met the criteria in the previous directive.

FDA’s Response to Baby Formula Shortage

This year the Food and Drug Administration (FDA) has come under fire for its slow response to the nationwide baby formula shortage. In September 2022, FDA Commissioner Robert M. Califf authorized the release of an internal report. The report details how the baby formula shortage occurred, the FDA’s response to the shortage, and the challenges it faced in resolving the shortage. The report also revealed the changes in FDA regulatory procedure to ensure another shortage does not occur. 

SEC Proposes Rules to Combat Cyber-Attacks

On March 9, 2022, the U.S. Securities and Exchange Commission (SEC) proposed rules on Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure by Public Companies. In an attempt to further protect against cybersecurity attacks and increase cyber transparency among issuers and investors President Biden signed into law the Cyber Incident Reporting for Critical Infrastructure Act of 2022 (CIRCIA). Before CIRCIA goes into effect, it requires the Cybersecurity and Infrastructure Security Agency (CISA) to complete mandatory rulemaking activities, to develop/publish a Notice of Proposed Rulemaking (NPRM), and a final rule. The SEC proposal and CIRCIA both have different implications, but both will increase cybersecurity regulations and procedures, even making employees more conscious of potential attacks.

Our American Government: a Self-Serving Entity?

As of September 2022, the current Congress has an approval rating of just 17% – an ignominious reality – and a series of recent investigations won’t serve to ease the mounting public frustration. Insider recently identified at least 72 members of Congress in noncompliance with the Stop Trading on Congressional Knowledge Act (STOCK). This revelation – among others – has prompted a push for the enactment of more stringent congressional stockholding limitations.

Possible Pitfalls in Michigan State’s Certification of Title IX 

On Friday, September 30th, the Michigan State University Board of Trustees released an audit conducted earlier this month on the Title IX certification process. This audit was conducted after concerns arose regarding failure of compliance with the state-mandated Title IX certification process last year. Michigan State University President, Samuel Stanley, is at the forefront of the investigations. 

The Mahsa Amini Protests: The Fight for Freedom and Women’s Rights in Iran

On September 16, 2022, a 22-year-old Iranian woman named Mahsa Amini died on her third day in police custody after being arrested for allegedly violating Iran’s strict dress code rules by wearing her hijab too loosely. While Iranian authorities claim that Ms. Amini died of heart failure, her family and protestors across the country are alleging that she was killed by law enforcement. Thousands of Iranians have taken to the streets to protest, which has led to demonstrations in over 40 cities across Iran, resulted in thousands of arrests and dozens of deaths from clashes with security forces, and the implementation of communication restrictions by the Iranian government. Now, the United Nations and its member countries are taking action in response to Iran’s persistent violations of the International Covenant on Civil and Political Rights treaty, to which they are signatories.

Artificial Intelligence: The Next Regulatory Frontier

Until recently, Artificial Intelligence (AI) was the domain of science fiction connoisseurs and Silicon Valley tech savants. Now, AI is ubiquitous in our daily lives, with a seemingly endless number of possible applications. As with any new and emerging technology, there are many novel questions and concerns that need to be addressed. Whether it be related to copyright ownership, ethics, cybersecurity obstacles, or discrimination and bias, concerns surrounding AI usage are mounting. AI system regulation has been rapidly increasing worldwide, while the U.S. regulatory landscape has remained relatively sparse. But it won’t be for long.

Got (Plant) Milk? The Rise and Regulation of the Alternative Meat and Dairy Markets

The plant-based food market has been exploding in recent years, with the plant-based meat market expected to reach a value of $7.4 billion by the end of 2022 and the alternative dairy market reaching a value of $23.2 billion in 2021.

The meat and dairy alternative markets require regulation, but despite their widespread and growing popularity, the U.S. Food and Drug Administration (FDA) has been slow to issue regulations that encompass these markets. In January 2022, the FDA released a list of draft and final guidance topics that it intends to complete before the end of 2022. These topics include draft guidance for plant-based dairy alternatives, plant-based meat alternatives, and for cultured meat. The FDA is soliciting public comments on the proposed guidance, although as of now none of the draft guidance topics have been released to the public